Currency in USD
Earnings Estimate | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
---|
No. of Analysts | 1 | 1 | 3 | 3 |
Avg. Estimate | 0.87 | 0.9 | 3.66 | 3.94 |
Low Estimate | 0.87 | 0.9 | 3.51 | 3.76 |
High Estimate | 0.87 | 0.9 | 3.8 | 4.05 |
Year Ago EPS | 1.09 | 0.87 | 3.44 | 3.66 |
Revenue Estimate | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
---|
No. of Analysts | 2 | 2 | 3 | 3 |
Avg. Estimate | 8.02B | 8.26B | 34.56B | 37.13B |
Low Estimate | 7.95B | 8.23B | 34.39B | 36.13B |
High Estimate | 8.08B | 8.28B | 34.83B | 38.39B |
Year Ago Sales | 13.11B | 8.7B | 36.1B | 34.56B |
Sales Growth (year/est) | -38.80% | -5.10% | -4.30% | 7.40% |
Earnings History | 3/30/2022 | 6/29/2022 | 9/29/2022 | 12/30/2022 |
---|
EPS Est. | 0.92 | 0.73 | 0.96 | 0.5 |
EPS Actual | 1.09 | 0.87 | 1.1 | 0.6 |
Difference | 0.17 | 0.14 | 0.14 | 0.1 |
Surprise % | 18.50% | 19.20% | 14.60% | 20.00% |
EPS Trend | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
---|
Current Estimate | 0.87 | 0.9 | 3.66 | 3.94 |
7 Days Ago | 0.87 | 0.9 | 3.66 | 3.94 |
30 Days Ago | 0.9 | 0.93 | 3.66 | 3.96 |
60 Days Ago | 0 | 0 | 3.62 | 4 |
90 Days Ago | 0 | 0 | 3.69 | 4.15 |
EPS Revisions | Current Qtr. (Mar 2023) | Next Qtr. (Jun 2023) | Current Year (2023) | Next Year (2024) |
---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | 1 | 1 |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | GSK | Industry | Sector(s) | S&P 500 |
---|
Current Qtr. | -20.20% | N/A | N/A | N/A |
Next Qtr. | 3.40% | N/A | N/A | N/A |
Current Year | 6.40% | N/A | N/A | N/A |
Next Year | 7.70% | N/A | N/A | N/A |
Next 5 Years (per annum) | 5.30% | N/A | N/A | N/A |
Past 5 Years (per annum) | -2.06% | N/A | N/A | N/A |